WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Patient Registry: Partial Breast Irradiation

Terminated

Conditions: Breast Cancer

First Posted Date: 2010-05-21

Last Posted Date: 2024-10-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 145

Registration Number: NCT01127971

Locations: 🇺🇸
Aurora BayCare Medical Center, Green Bay, Wisconsin, United States

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Not Applicable

Completed

Conditions: Advanced Malignant Mesothelioma
Carcinoma of the Appendix
Stage III Ovarian Germ Cell Tumor
Ovarian Sarcoma
Recurrent Malignant Mesothelioma
Stage IV Colon Cancer
Pseudomyxoma Peritonei
Recurrent Ovarian Epithelial Cancer
Recurrent Ovarian Germ Cell Tumor
Stage IV Ovarian Epithelial Cancer

Interventions: Behavioral: HIPEC Orientation
Behavioral: Consultation with Survivorship Navigator
Other: Questionnaires

First Posted Date: 2010-05-19

Last Posted Date: 2018-07-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT01126346

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm

Completed

Conditions: Dementia

First Posted Date: 2010-05-17

Last Posted Date: 2017-11-06

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1362

Registration Number: NCT01124773

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Intraosseous Versus Intravenous Vascular Access During Cardiac Arrest

Not Applicable

Completed

Conditions: Cardiac Arrest

Interventions: Device: Intravenous access during OHCA
Device: Humeral IO insertion
Device: TIbial IO insertion

First Posted Date: 2010-05-10

Last Posted Date: 2022-06-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 182

Registration Number: NCT01119807

Locations: 🇺🇸
Mecklenburg EMS Agency, Charlotte, North Carolina, United States

Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors

Not Applicable

Completed

Conditions: Stage IIIA Breast Cancer
Stage IV Breast Cancer
Stage I Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Stage II Breast Cancer

Interventions: Other: questionnaire administration
Behavioral: exercise intervention
Procedure: quality-of-life assessment
Other: survey administration
Procedure: management of therapy complications
Procedure: psychosocial assessment and care

First Posted Date: 2010-04-30

Last Posted Date: 2018-07-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 26

Registration Number: NCT01113554

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Phase 2

Completed

Conditions: Male Erectile Disorder
Prostate Cancer
Radiation Toxicity

Interventions: Other: Placebo
Drug: Oral L-Arginine

First Posted Date: 2010-04-16

Last Posted Date: 2021-09-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 140

Registration Number: NCT01105130

Locations: 🇺🇸
W F Baptist Health, Winston-Salem, North Carolina, United States

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Phase 1

Terminated

Conditions: Adult Anaplastic Oligodendroglioma
Recurrent Adult Brain Tumor
Adult Diffuse Astrocytoma
Adult Giant Cell Glioblastoma
Adult Anaplastic Astrocytoma
Adult Glioblastoma
Adult Gliosarcoma
Adult Mixed Glioma
Adult Oligodendroglioma

Interventions: Drug: erlotinib hydrochloride
Drug: isotretinoin
Other: laboratory biomarker analysis
Genetic: protein expression analysis

First Posted Date: 2010-04-14

Last Posted Date: 2018-08-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 5

Registration Number: NCT01103375

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis

Phase 4

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Atopiclair Nonsteroidal Cream
Other: Aquaphor Healing Ointment
Drug: EpiCeram

First Posted Date: 2010-03-25

Last Posted Date: 2018-09-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 39

Registration Number: NCT01093469

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux

Completed

Conditions: Gastroesophageal Reflux Disease (GERD)

First Posted Date: 2010-03-24

Last Posted Date: 2017-04-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 143

Registration Number: NCT01091805

Locations: 🇺🇸
Wake Forest University Baptist Medical Center, Winston Salem, North Carolina, United States

Building Social Networks to Enhance Postpartum Weight Loss and Appropriate Infant Feeding Practices

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Home visit
Behavioral: Social network building intervention

First Posted Date: 2010-03-05

Last Posted Date: 2018-08-13

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 41

Registration Number: NCT01081340

Locations: 🇺🇸
Coleman Regional Community Center - Parks & Rec Department, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy